Edition:
United States

Kyorin Holdings Inc (4569.T)

4569.T on Tokyo Stock Exchange

2,314JPY
7:31pm EST
Change (% chg)

¥-41 (-1.74%)
Prev Close
¥2,355
Open
¥2,305
Day's High
¥2,331
Day's Low
¥2,305
Volume
81,900
Avg. Vol
162,399
52-wk High
¥2,662
52-wk Low
¥1,842

4569.T

Chart for 4569.T

About

KYORIN Holdings, Inc. is a Japan-based holding company mainly engaged in the manufacture and sale of pharmaceuticals. The Company operates in two business segments. The Pharmaceuticals segment is engaged in the manufacture, purchase and sale of pharmaceutical products, the evaluation of technologies, the inspection, analysis and... (more)

Overall

Beta: 0.65
Market Cap(Mil.): ¥176,876.41
Shares Outstanding(Mil.): 74.95
Dividend: 38.00
Yield (%): 2.46

Financials

  4569.T Industry Sector
P/E (TTM): 13.06 30.04 30.65
EPS (TTM): 180.66 -- --
ROI: 8.24 15.86 15.23
ROE: 8.75 16.96 16.56

BRIEF-KYORIN Holdings unit grants MSD K.K. manufacturing and marketing rights for medicine of allergic diseases

* Says MSD K.K. received a manufacturing and marketing approval for DESALEX Tablets 5mg for the treatment of allergic diseases from the co's unit KYORIN Pharmaceutical Co., Ltd.

Sep 28 2016

BRIEF-KYORIN Holdings unit enters into co-promotion agreement with MSD K.K

* Says its unit Kyorin Pharmaceutical Company Limited enters into agreement with MSD K.K, on co-promotion of an allergic rhinitis treatment, since Nov. 1

Sep 15 2016

BRIEF-Kaken Pharmaceutical to co-promote allergic medicine with Kyorin Holdings unit

* Says the company entered into basic agreement with Kyorin Holdings Inc 's unit on co-promotion of an allergic medicine, whose exclusive sales right is owned by the Kyorin Holdings's unit

Jul 11 2016

Earnings vs. Estimates